pharma · Solid Tumors · Primary Dysmenorrhea
Topiloric/Uriadec
Topiloric/Uriadec trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
- Status
- Public
- HQ
- SOUTH SAN FRANCISCO, CA, JP
- Employees
- 2
- Programs
- 12
- Drugs
- 7
- Patents
- 52
Topiloric/Uriadec clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Topiloric/Uriadec programs — each row shows trial ID, program name, phase, status, and indication.
Topiloric/Uriadec trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Topiloric/Uriadec.
-
AgnoMed — Phase 3
Clinical update -
SilMAKin — Phase 1
Clinical update -
ORIC-114 Dose 1 + amivantamab — Phase 1
Clinical update -
ORIC-533 — Phase 1
Clinical update -
Ph 1 Study of ORIC-944 in Patients with Metastatic Prostate Cancer. — Phase 1
Clinical update -
ORIC-114 — Phase 2
Clinical update -
ORIC-114 — Phase 2
Clinical update -
ORIC-101 — Phase 1
Clinical update